We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Vaccine panel urges extra safety towards RSV, meningitis and chikungunya
Health

Vaccine panel urges extra safety towards RSV, meningitis and chikungunya

Last updated: April 17, 2025 5:30 pm
Editorial Board Published April 17, 2025
Share
SHARE

by I. Edwards

A panel of federal well being consultants on Wednesday advisable expanded vaccine choices for a number of illnesses, together with respiratory syncytial virus (RSV), meningitis and a mosquito-borne sickness referred to as chikungunya.

The panel, often called the Advisory Committee on Immunization Practices (ACIP), makes vaccine use suggestions to the director of the U.S. Facilities for Illness Management and Prevention (CDC), The Related Press reported.

These suggestions are nearly at all times accredited. However current management modifications on the CDC could complicate subsequent steps.

Performing Director Susan Monarez, who’s President Donald Trump’s choose to steer the CDC, awaits U.S. Senate affirmation. Till that occurs, she has recused herself from common duties as a result of federal regulation concerning vaccines.

In keeping with two CDC officers who spoke anonymously, selections could now fall to U.S. Well being Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist.

The brand new suggestions embody:

Adults aged 50 to 59 with sure well being issues, like coronary heart illness, diabetes or persistent obstructive pulmonary dysfunction ought to have the ability to get the RSV shot.
A brand new mixture vaccine from GSK was endorsed. It protects towards 5 varieties of meningococcal micro organism, together with one linked to school campus outbreaks about 10 years in the past.
A second vaccine for chikungunya was advisable for vacationers age 12 and older heading to international locations with present outbreaks. About 100 to 200 instances of chikungunya are reported annually amongst U.S. vacationers.
A security warning was added to an older chikungunya vaccine that makes use of a weakened reside virus. Folks 65 and older ought to talk about the dangers with their physician, particularly in the event that they produce other well being situations. This follows reviews of six older adults growing coronary heart or mind signs shortly after getting the shot. The instances are nonetheless being investigated.

Extra data:
Be taught extra about vaccines on the Mayo Clinic.

© 2025 HealthDay. All rights reserved.

Quotation:
Vaccine panel urges extra safety towards RSV, meningitis and chikungunya (2025, April 17)
retrieved 17 April 2025
from https://medicalxpress.com/information/2025-04-vaccine-panel-urges-rsv-meningitis.html

This doc is topic to copyright. Other than any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for data functions solely.

You Might Also Like

Actual-world proof hyperlinks long-term use of oral and inhaled steroids to adrenal insufficiency

Measles roars again within the US, topping 1,000 circumstances

Examine finds phthalates might alter genital measurements in 3-year-olds

Needle-free, live-attenuated influenza vaccines with broad safety in opposition to human and avian virus subtypes

Tips up to date for nonoccupational postexposure prophylaxis for HIV

TAGGED:chikungunyaMeningitispanelProtectionRSVurgesvaccine
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Mark Shields, TV Pundit Known for His Sharp Wit, Dies at 85
Politics

Mark Shields, TV Pundit Known for His Sharp Wit, Dies at 85

Editorial Board June 18, 2022
Google’s Agent2Agent interoperability protocol goals to standardize agentic communication
Discovery may remove must refrigerate vaccines and protein-based medication
NoViolet Bulawayo Believes Freedom Begins With Imagination
Fresh Strawberries Linked to Hepatitis A Outbreak, F.D.A Says

You Might Also Like

Intraocular irritation extra widespread with aflibercept injections in real-world setting
Health

Intraocular irritation extra widespread with aflibercept injections in real-world setting

May 10, 2025
Probiotic supplementation might assist cut back chemotherapy uncomfortable side effects in breast most cancers
Health

Probiotic supplementation might assist cut back chemotherapy uncomfortable side effects in breast most cancers

May 10, 2025
Examine exhibits a digital nurse can persuade you to get vaccinated
Health

Examine exhibits a digital nurse can persuade you to get vaccinated

May 10, 2025
Research level to redlining as a ‘excellent storm’ for breast most cancers
Health

Research level to redlining as a ‘excellent storm’ for breast most cancers

May 10, 2025

Categories

  • Health
  • Politics
  • Sports
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?